Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss

Journal Title: Bengal Journal of Otolaryngology and Head Neck Surgery - Year 2017, Vol 25, Issue 2

Abstract

IntroductionSteroid therapy is considered to be the gold standard for sudden sensorineural hearing loss (SSNHL). Delivering steroids by intratympanic injection is more efficient than systemic injections with minimum or no side effects. The present study was aimed to evaluate the efficacy and safety of intratympanic methylprednisolone injections as initial first line therapy for unilateral idiopathic SSNHL and the ease of giving it by otoendoscopy.Materials and MethodsA prospective analysis was performed for the patients diagnosed as unilateral idiopathic SSNHL from April 2014 to April 2016 and receiving intratympanic steroids injections as first line therapy. Patients with unilateral sensorineural hearing loss of at least 30 dB at 3 contiguous frequencies occurring within a period of not more than 3 days are only included. All of the intratympanic steroid (ITS) injections were administered as OPD procedures. Each patient was treated by 3 injections given at 3 days interval. ResultsA total of 22 patients who underwent primary intratympanic steroid (ITS) injection for unilateral SSNHL during the study period were included in the study. The mean age was 42.22 years (+ 9.79) and age ranged from 27 to 68 years. Patients included in our study came within 2nd to 27th day of occurrence of deafness and the mean duration (days) from onset of disease to start of ITS was 7.86 days. The average hearing gain in our study was 44.22 dB. In the present study 11 patients (50%) showed complete hearing improvement and 10 cases (45.45%) had partial and one (4.54%) showed no hearing recovery at 3 weeks follow up period.ConclusionMinimal systemic absorption with minimum or no systemic effects and high percentage of success rate encouraged the surgeons to prefer ITS as primary therapy for idiopathic unilateral SSNHL. It is effective, cheap, well-tolerated and can be performed as OPD procedure. 

Authors and Affiliations

Mukul Patar, Rupanjita Sangma

Keywords

Related Articles

Surgical approach to Parapharyngeal Tumours - Our Experience

IntroductionThe complex anatomy of the parapharyngeal space, the surrounding vital structures and late presentation of the tumours affecting this space pose difficult surgical challenge to every otolaryngologist. The stu...

Intralesional Sclerotherapy with Polidocanol in the Management of Head and Neck Vascular Lesions

 IntroductionVascular lesions (Hemangioma or vascular malformation) in the head and neck region are quite common and need therapeutic intervention if they become symptomatic or cosmetically unacceptable. Different therap...

The Incidence of Thyroid Cancer in England and Wales over A Ten-Year Period

IntroductionThe incidence of thyroid cancer has increased worldwide, whether a real or apparent increase is debated. Literature from the USA suggests greater diagnostic scrutiny, environmental and genetic factors may all...

Rhinosporidiosis: Various Presentations and Different Sites

IntroductionRhinosporidiosis commonly affects nasal mucosa but may have varied presentations depending upon the site of involvement.Materials and Methods119 patients of rhinosporidiosis, attending the two medical college...

An uncommon experience during removal of a foreign body from ear of a child

A difficult to extract geoid bead was successfully removed from the middle ear cavity by threading it with monofilament polypropylene without drill-out of the bony annulus or widening the isthmus of the external auditory...

Download PDF file
  • EP ID EP433957
  • DOI -
  • Views 59
  • Downloads 0

How To Cite

Mukul Patar, Rupanjita Sangma (2017). Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss. Bengal Journal of Otolaryngology and Head Neck Surgery, 25(2), 69-74. https://europub.co.uk/articles/-A-433957